Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs144834613 | chr17:1420447 | C/CGGCT | 1.74E-5 | 172 | 25.47 | 25.87 | 1.2 | KM Plot |
PCPG | rs144841076 | chr12:124038455 | CTAAT/C | 0.000484 | 172 | 25.87 | 19.2 | 20.13 | KM Plot |
PCPG | rs144865423 | chr10:50529337 | CAAGT/C | 3.6E-6 | 176 | 24.52 | 35.5 | 25.17 | KM Plot |
PCPG | rs144886737 | chr9:36129215 | TCTC/T | 0 | 176 | 25.53 | 26.05 | 2.93 | KM Plot |
PCPG | rs144942369 | chr7:105163931 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs145013992 | chr10:69733697 | G/A | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs145098995 | chr9:86432404 | C/A | 0.000168 | 171 | 26.57 | 23.43 | 14.47 | KM Plot |
PCPG | rs145286577 | chr12:56715584 | G/A | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs145305594 | chr2:118525376 | C/T | 1.5E-5 | 178 | 25 | 30.33 | 11.65 | KM Plot |
PCPG | rs145344160 | chr8:53846426 | T/TGGCAAATTTGAA | 5.59E-5 | 171 | 24.47 | 27.2 | 20 | KM Plot |
PCPG | rs145429157 | chr7:158655672 | C/G | 0 | 176 | 25.53 | 19.83 | 3.17 | KM Plot |
PCPG | rs145469499 | chr1:66916509 | G/GA | 9.06E-9 | 175 | 25.6 | 23.82 | 3.17 | KM Plot |
PCPG | rs145595621 | chr6:147376375 | CT/C | 7.61E-6 | 176 | 25.67 | 19.72 | 4.67 | KM Plot |
PCPG | rs1456690 | chr6:122600775 | A/T | 4.52E-6 | 174 | 27.3 | 21.95 | 15.08 | KM Plot |
PCPG | rs145812054 | chr2:118585588 | C/T | 1.92E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |